ACADIA Pharmaceuticals (ACAD)

Add to Watchlists
Create an Alert
19.44 +0.16  +0.83% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
ACAD Price Chart
View All Events

ACAD Events

Date Type Description
Mar 05 Misc ACADIA Pharmaceuticals at Raymond James Financial Inc Institutional Investors Conference
Feb 27 Misc Q4 2013 ACADIA Pharmaceuticals Earnings Conference Call
Feb 20 Earnings Q4 2013 ACADIA Pharmaceuticals Earnings Results. Estimate: -0.13.
Nov 06 Misc ACADIA Pharmaceuticals Q3 2013 Conference Call
Nov 06 Earnings ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013. Estimate: -0.12.
Aug 06 Misc Q2 2013 ACADIA Pharmaceuticals Earnings Conference Call
Aug 06 Earnings Second Quarter 2013 Financial Results. Estimate: -0.08.
Jun 07 Misc AGM Event for Acadia Pharmaceuticals Inc
May 07 Misc Q1 2013 ACADIA Pharmaceuticals Earnings Conference Call
May 07 Earnings ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013. Estimate: -0.08.
View All Performance Charts

ACAD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ACADIA Pharmaceuticals is up 57.79% over the last year vs S&P 500 Total Return up 23.54%, Arena Pharmaceuticals down 23.33%, and Alexion Pharmaceuticals up 58.10%.

Get Quote for

PDF Report for ACAD

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACAD Pro Report PDF
Advertisement

Portfolio Strategies Featuring ACAD

Did ACADIA Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACAD Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

ACADIA Pharmaceuticals, Inc. is in the business of development and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ACAD 19.44 +0.16 +0.83% 1.776B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.